OR

355.15

+0.94%↑

B.US

41.61

+4.94%↑

ASM

669

+4.86%↑

IAG.ES

4.2

+2.94%↑

UPM.FI

26.95

+0.07%↑

OR

355.15

+0.94%↑

B.US

41.61

+4.94%↑

ASM

669

+4.86%↑

IAG.ES

4.2

+2.94%↑

UPM.FI

26.95

+0.07%↑

OR

355.15

+0.94%↑

B.US

41.61

+4.94%↑

ASM

669

+4.86%↑

IAG.ES

4.2

+2.94%↑

UPM.FI

26.95

+0.07%↑

OR

355.15

+0.94%↑

B.US

41.61

+4.94%↑

ASM

669

+4.86%↑

IAG.ES

4.2

+2.94%↑

UPM.FI

26.95

+0.07%↑

OR

355.15

+0.94%↑

B.US

41.61

+4.94%↑

ASM

669

+4.86%↑

IAG.ES

4.2

+2.94%↑

UPM.FI

26.95

+0.07%↑

Search

Tessenderlo Group SA

Atvērts

SektorsPamatmateriāli

20.45 4.34

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

19.6

Max

20.5

Galvenie mērījumi

By Trading Economics

Ienākumi

-9.5M

Pārdošana

1.5B

EPS

-0.16

Dividenžu ienesīgums

3.62

Peļņas marža

-0.639

Darbinieki

7,000

EBITDA

162M

Dividendes

By Dow Jones

Dividenžu ienesīgums

Sektora vidējais

3.62%

2.88%

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

1.2B

Iepriekšējā atvēršanas cena

16.11

Iepriekšējā slēgšanas cena

20.45

Ziņu noskaņojums

By Acuity

50%

50%

74 / 150 Rangs Basic materials

Tessenderlo Group SA Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 31. marts 23:31 UTC

Karstas akcijas

Stocks to Watch: Nike, RH, NCino

2026. g. 31. marts 22:35 UTC

Peļņas

Nike Guides for Sales Declines Ahead as Turnaround Plan Hits Snags -- 2nd Update

2026. g. 1. apr. 00:00 UTC

Iegādes, apvienošanās, pārņemšana

The Year Is Off to the Strongest Start for Big Deals Ever -- WSJ

2026. g. 31. marts 23:50 UTC

Iegādes, apvienošanās, pārņemšana

Nxera Pharma: Partner Centessa Pharmaceuticals to Be Acquired by Lilly >LLY 4565.TO

2026. g. 31. marts 23:43 UTC

Tirgus saruna

Nikkei May Rise on Hopes for Iran War Ending Soon -- Market Talk

2026. g. 31. marts 23:33 UTC

Tirgus saruna
Galvenie ziņu notikumi

Gold Edges Higher on Signs of De-Escalating Middle East Tensions -- Market Talk

2026. g. 31. marts 23:21 UTC

Peļņas

Nike Stock Slides on Tariff Impact Despite Earnings Beat; Turnaround Continues -- Barrons.com

2026. g. 31. marts 23:14 UTC

Tirgus saruna
Peļņas

Nike CEO Says Turnaround is Taking Longer Than He'd Like -- Market Talk

2026. g. 31. marts 23:12 UTC

Tirgus saruna

Aurelia's Cash Flow Strength Highlighted by New Financing Deal -- Market Talk

2026. g. 31. marts 22:36 UTC

Peļņas

China Vanke 2025 Loss Widens >000002.SZ

2026. g. 31. marts 22:36 UTC

Peļņas

China Vanke: Increase in Inventory Impariment Provision Among Factors Weighing On Results>000002.SZ

2026. g. 31. marts 22:36 UTC

Peļņas

China Vanke 2025 Loss CNY88.56B Vs. Loss CNY49.48B >000002.SZ

2026. g. 31. marts 22:36 UTC

Peļņas

China Vanke: Will Take Time to Resolve Issues Caused by High Debt Levels>000002.SZ

2026. g. 31. marts 22:36 UTC

Peļņas

China Vanke 2025 Rev CNY233.43B Vs. CNY343.18B >000002.SZ

2026. g. 31. marts 21:46 UTC

Iegādes, apvienošanās, pārņemšana

Big Drug Companies Hunting for Deals Are Lowering Their Sights -- WSJ

2026. g. 31. marts 21:36 UTC

Tirgus saruna

West African Resources's Costs Higher Than Bull Expected -- Market Talk

2026. g. 31. marts 21:35 UTC

Peļņas

Nike Expects China Sales Down 20% in 4Q, CFO Says

2026. g. 31. marts 21:35 UTC

Peļņas

Nike Expects Modest Growth in North America, Offset by Declines in China, Converse Brand in 4Q, CFO Says

2026. g. 31. marts 21:35 UTC

Peļņas

Nike Forecasts 4Q Sales Down 2% to 4%, CFO Says

2026. g. 31. marts 21:33 UTC

Iegādes, apvienošanās, pārņemšana

Biotechs Are a Healthy Growth Bet Thanks to M&A and New Drugs -- Barrons.com

2026. g. 31. marts 21:33 UTC

Peļņas

Nike Expects Sales Down Low-Single Digits From Now Through End of Calendar Year, CFO Says

2026. g. 31. marts 21:32 UTC

Peļņas

Nike Expects 1Q to Be Final Quarter Where Tariffs Continue to Be Year-Over-Year Headwind to Margins, CFO Says

2026. g. 31. marts 21:28 UTC

Peļņas

Nike Expects to End 4Q With Elevated Inventory, CFO Says

2026. g. 31. marts 21:26 UTC

Peļņas

Nike Increasingly Confident It Will Return to Balanced Growth in North America in Direct, Wholesale Channels, CFO Says

2026. g. 31. marts 21:25 UTC

Peļņas

Nike Expects Supply-Chain Changes to Pay Off Starting in Fiscal 2027, CFO Says

2026. g. 31. marts 21:24 UTC

Tirgus saruna
Peļņas

Nike: Turnaround Plan Progressing at Different Rates -- Market Talk

2026. g. 31. marts 21:22 UTC

Peļņas

Nike CFO Expects Football Training and Basketball Will Return to Growth Over Next Few Quarters

2026. g. 31. marts 21:22 UTC

Peļņas

Nike's Sportswear Business Declined Low-Double Digits in 3Q, CFO Says

2026. g. 31. marts 21:21 UTC

Peļņas

Nike's Digital Channel Still Too Promotional, CFO Says

2026. g. 31. marts 21:20 UTC

Peļņas

Nike CEO: Converse Remains Important to Portfolio

Salīdzinājums

Cenas izmaiņa

Tessenderlo Group SA Prognoze

Noskaņojums

By Acuity

74 / 150 Rangs Pamatmateriāli

Ziņu noskaņojums

Neutral

Volatilitāte

Zem vidējā

Ziņu apjoms (RCV)

Zem vidējā

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par Tessenderlo Group SA

Tessenderlo Group NV, together with its subsidiaries, engages in the agriculture, valorizing bio-residuals, energy, and industrial solution businesses worldwide. It operates through five segments: Agro, Bio-Valorization, Industrial Solutions, Machines & Technologies, and T-Power. The Agro segment engages in the production, marketing, and trading of crop nutrients, including liquid crop and potassium sulfate fertilizers, and organic soil improvers, as well as organic and non-organic crop protection products. This segment offers its specialty fertilizers under Thio-Sul, KTS, K-Row 23, CaTs, GranuPotasse, SoluKem, SoluPotasse, and MAJOR 90 brands. The Bio-Valorization segment produces, sells, and trades in gelatins and collagen peptides, and proteins and fats. The Industrial Solutions segment is involved in the provision of preassembled piping kits, project consultancy services, engineering support for ventilation solutions, sewage and rainwater solutions, and siphonic roof drainage systems; coagulants and other chemicals for the treatment of wastewater, and the purification of drinking water; production and sale of industrial chemicals, such as bleach, sulfuric acid, sodium hydroxide, various grades of hydrochloric acid, and calcium chloride, as well as sulfur chemicals. The Machines & Technologies segment engages in the design, development, production, sale, support, and service of weaving machines, as well as related upgrade kits and spare parts, and training and repair services; engineered casting solutions, and drill tips and anchor solutions; customized controller systems; and precision parts. The T-Power segment produces electricity through a combined cycle gas turbine of 425 MW capacity. It serves agriculture, food, pharma, municipal water, mining, construction, infrastructure, health, chemical, oil and gas, textile, animal feed, machinery, engineering, and consumer goods end markets. The company was founded in 1919 and is headquartered in Brussels, Belgium.
help-icon Live chat